WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

Analyst price target for JNJ

Based on 5 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$180.00+9.12%
Avg Forecast
$188.60+14.33%
Max Forecast
$200.00+21.24%

Should I buy or sell JNJ stock?

Strong Buy
Strong Buy
2 analysts 40%
Buy
3 analysts 60%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

JNJ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
Morgan Stanley
Strong BuyMaintains$187.00+13.36%2021-01-27
Louise Chen
Cantor Fitzgerald
Strong BuyMaintains$180.00+9.12%2020-10-14
Jayson Bedford
Raymond James
BuyMaintains$183.00+10.94%2021-01-27
Matt Miksic
Credit Suisse
BuyMaintains$193.00+17.00%2021-01-27
Danielle Antalffy
SVB Leerink
BuyMaintains$200.00+21.24%2021-01-27

1 of 1

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
46.16%
Industry
71.19%
Market
61.4%
JNJ's Return on Equity is forecast to be high in 3 years (46.16%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
17.61%
Industry
16.07%
Market
18.88%
JNJ is forecast to generate higher Return on Assets (17.61%) than the US Drug Manufacturers - General industry average (16.07%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$9.51+65.64%
Avg 2 year Forecast
$10.31+79.67%
Avg 3 year Forecast
$11.05+92.51%
JNJ's earnings are forecast to grow at an exceptional rate of 24.5% per year
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$91.8B+8.97%
Avg 2 year Forecast
$96.7B+14.77%
Avg 3 year Forecast
$101.2B+20.13%
JNJ's revenue is forecast to grow at a rate of 6.34% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
24.5%
Industry
29.96%
Market
19.68%
JNJ's earnings are forecast to grow slower (24.5% per year) than the US Drug Manufacturers - General industry average (29.96%)
Forecast
JNJ's earnings are forecast to grow faster (24.5% per year) than the US market average (19.68%)
Forecast
JNJ's earnings are forecast to grow faster (24.5% per year) than the risk-free savings rate (1.5%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
6.34%
Industry
5.36%
Market
14.56%
JNJ's revenues are forecast to grow faster (6.34% per year) than the US Drug Manufacturers - General industry average (5.36%)
Forecast
JNJ's revenues are forecast to grow slower (6.34% per year) than the US market average (14.56%)
Forecast

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: JNJ) stock is to Strong Buy JNJ stock.

Out of 5 analysts, 2 (40%) are recommending JNJ as a Strong Buy, 3 (60%) are recommending JNJ as a Buy, 0 (0%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

What is JNJ's earnings growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 24.5% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 29.96%, and while it is forecast to beat the US market's average forecast earnings growth rate of 19.68%.

Johnson & Johnson's earnings in 2021 is $15,115,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $25,037,802,517, with the lowest JNJ earnings forecast at $24,806,590,348, and the highest JNJ earnings forecast at $25,201,599,749. On average, 9 Wall Street analysts forecast JNJ's earnings for 2022 to be $27,159,002,998, with the lowest JNJ earnings forecast at $26,728,969,430, and the highest JNJ earnings forecast at $28,072,001,392.

In 2023, JNJ is forecast to generate $29,099,025,833 in earnings, with the lowest earnings forecast at $28,519,678,712 and the highest earnings forecast at $29,415,033,354.

What is JNJ's revenue growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 6.34% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.56%.

Johnson & Johnson's revenue in 2021 is $84,214,000,000.On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $241,671,591,377,164, with the lowest JNJ revenue forecast at $240,049,846,049,468, and the highest JNJ revenue forecast at $245,816,430,282,877. On average, 5 Wall Street analysts forecast JNJ's revenue for 2022 to be $254,527,993,934,362, with the lowest JNJ revenue forecast at $251,355,015,090,347, and the highest JNJ revenue forecast at $259,768,899,657,652.

In 2023, JNJ is forecast to generate $266,421,068,632,910 in revenue, with the lowest revenue forecast at $263,847,845,728,579 and the highest revenue forecast at $268,084,979,897,406.

What is JNJ's forecast return on assets (ROA) for 2021-2024?

(NYSE: JNJ) forecast ROA is 17.61%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.07%.

What is JNJ's Price Target?

According to 5 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $188.60, with the highest JNJ stock price forecast at $200.00 and the lowest JNJ stock price forecast at $180.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could stay at $188.60 by Jan 27, 2022. The average Johnson & Johnson stock price prediction forecasts a potential downside of N/A from the current JNJ share price of $164.96.

What is JNJ's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $5.74. On average, analysts forecast that JNJ's EPS will be $9.51 for 2021, with the lowest EPS forecast at $9.42, and the highest EPS forecast at $9.57. On average, analysts forecast that JNJ's EPS will be $10.31 for 2022, with the lowest EPS forecast at $10.15, and the highest EPS forecast at $10.66. In 2023, JNJ's EPS is forecast to hit $11.05 (min: $10.83, max: $11.17).

What is JNJ's forecast return on equity (ROE) for 2021-2024?

(NYSE: JNJ) forecast ROE is 46.16%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.